Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 637

Related Citations for PubMed (Select 15823382)


Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.

Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.

Lancet. 2005 Apr 9-15;365(9467):1321-8.


Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.

West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC.

Lancet. 2005 Oct 8;366(9493):1296-300.


Mass treatment with single-dose azithromycin for trachoma.

Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.

N Engl J Med. 2004 Nov 4;351(19):1962-71.


Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

Burton MJ, Holland MJ, Makalo P, Aryee EA, Sillah A, Cohuet S, Natividad A, Alexander ND, Mabey DC, Bailey RL.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e835. doi: 10.1371/journal.pntd.0000835.


A rationale for continuing mass antibiotic distributions for trachoma.

Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.

BMC Infect Dis. 2007 Aug 7;7:91.


Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.

West ES, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Bailey R, Foster A, Mabey D, West SK.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):83-7.


Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.

Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM.

Ophthalmology. 2009 Nov;116(11):2047-50. doi: 10.1016/j.ophtha.2009.04.041. Epub 2009 Sep 10.


Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Bailey RL, Arullendran P, Whittle HC, Mabey DC.

Lancet. 1993 Aug 21;342(8869):453-6.


Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.

Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.

Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4215-22.


Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.

Schémann JF, Guinot C, Traore L, Zefack G, Dembele M, Diallo I, Traore A, Vinard P, Malvy D.

Acta Trop. 2007 Jan;101(1):40-53. Epub 2006 Dec 16.


Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.

Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R; Partnership for Rapid Elimination of Trachoma (PRET) study group.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2115. doi: 10.1371/journal.pntd.0002115. Print 2013. Erratum in: PLoS Negl Trop Dis. 2013 Jun;7(6). doi:10.1371/annotation/0bae8b34-5ae7-4044-a071-8d88d520a01b.


Azithromycin in control of trachoma.

Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Mabey D, Faal H.

Lancet. 1999 Aug 21;354(9179):630-5.


Strategies for control of trachoma: observational study with quantitative PCR.

Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A, Massae PA, Mkocha H, Muñoz B, Johnson GJ, Peeling RW, Bailey RL, Foster A, Mabey DC.

Lancet. 2003 Jul 19;362(9379):198-204.


Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.

Yang JL, Hong KC, Schachter J, Moncada J, Lekew T, House JI, Zhou Z, Neuwelt MD, Rutar T, Halfpenny C, Shah N, Whitcher JP, Lietman TM.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):90-4. doi: 10.1167/iovs.08-2247. Epub 2008 Aug 8.


Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial.

West SK, Emerson PM, Mkocha H, McHiwa W, Munoz B, Bailey R, Mabey D.

Lancet. 2006 Aug 12;368(9535):596-600.


Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.

Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S.

Ophthalmic Epidemiol. 2011 Feb;18(1):20-9. doi: 10.3109/09286586.2010.545500.


Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC.

Bull World Health Organ. 2001;79(7):632-40.


When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.

Ray KJ, Lietman TM, Porco TC, Keenan JD, Bailey RL, Solomon AW, Burton MJ, Harding-Esch E, Holland MJ, Mabey D.

PLoS Negl Trop Dis. 2009 Jun 16;3(6):e458. doi: 10.1371/journal.pntd.0000458.


Three-day course of oral azithromycin vs topical oxytetracycline/polymyxin in treatment of active endemic trachoma.

Guzey M, Aslan G, Ozardali I, Basar E, Satici A, Karadede S.

Jpn J Ophthalmol. 2000 Jul-Aug;44(4):387-91.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk